Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

22.7%

115 terminated/withdrawn out of 507 trials

Success Rate

67.6%

-18.9% vs industry average

Late-Stage Pipeline

11%

54 trials in Phase 3/4

Results Transparency

41%

99 of 240 completed trials have results

Key Signals

80 recruiting99 with results67 terminated48 withdrawn

Enrollment Performance

Analytics

N/A

210(57.2%)

Phase 1

50(13.6%)

Phase 2

40(10.9%)

Phase 4

38(10.4%)

Phase 3

16(4.4%)

Early Phase 1

13(3.5%)

367Total

N/A(210)

Phase 1(50)

Phase 2(40)

Phase 4(38)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (507)

Showing 20 of 507 trials

NCT00106015Recruiting

Diamond Blackfan Anemia Registry (DBAR)

Role: lead

NCT05588063Not ApplicableRecruiting

taVNS for FRNS in Children

Role: lead

NCT05350150Not ApplicableActive Not Recruiting

Non-invasive Vagus Nerve Stimulation in Patients Undergoing Electrophysiological Study

Role: lead

NCT03587701Phase 2Recruiting

Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease

Role: lead

NCT02800486Phase 2Recruiting

Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA

Role: lead

NCT04228172Active Not Recruiting

Genotypic Influences on Network Progression in Parkinson's Disease

Role: lead

NCT05847192Recruiting

Tau Networks in Psychotic Alzheimer's Disease

Role: lead

NCT05408832Phase 2Completed

Personalized Trials for Stress Management Against Standard of Care

Role: lead

NCT07172282Early Phase 1Recruiting

INFINITIVE: ImmuNotherapy For PatIeNts wIth colorecTal LIVer MEtastases

Role: lead

NCT07483294Recruiting

Cerebellum-based Imaging Neural Markers for Antipsychotic Response

Role: lead

NCT05570851Not ApplicableActive Not Recruiting

Alcohol Cessation Among Head and Neck Cancer Survivors

Role: lead

NCT04055311Not ApplicableCompleted

Recovery Support for Bladder Cancer Patients and Caregivers

Role: lead

NCT07163273Phase 2Recruiting

Monthly Alternating NALIRIFOX and GnP in the First-Line Setting for Metastatic Pancreatic Ductal Adenocarcinoma

Role: lead

NCT05638945Not ApplicableCompleted

Determining the Preliminary Efficacy of the Emergency Department Delirium Screening and Detection Program

Role: lead

NCT07250113Not ApplicableEnrolling By Invitation

WeCareToFeedDysphagia to Reduce Care-partner Burden Full-scale RCT

Role: lead

NCT04755699Early Phase 1Recruiting

Chronic Transcutaneous Stimulation to Promote Motor Function and Recovery in Individuals With Paralysis or Paresis

Role: lead

NCT07032792Phase 2Recruiting

Factor VIII Inhibitor Bypass Activity (FEIBA) Versus Fresh Frozen Plasma As First Line Therapy For Bleeding After Cardiac Surgery

Role: lead

NCT07254091Early Phase 1Recruiting

Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Pancreatic Cancer

Role: lead

NCT06246149Phase 3Recruiting

Adjuvant Tebentafusp in High Risk Ocular Melanoma

Role: collaborator

NCT06801912Not ApplicableActive Not Recruiting

A BCT Intervention for an Hourly Activity Habit Among Caregivers for Persons With AD/ADRD

Role: lead